Published

The Potential of Psilocybin Administration in Terminal Cancer Patients

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Oncology Times
Date: 2019-06-28
Source: OpenAlex
DOI: 10.1097/01.cot.0000574916.46844.cf
PubMed: Unavailable

Authors

Richard Simoneaux

Watch author

Derived topics and classifications

psilocybin psilocin Depression Anxiety Addiction End-of-Life Distress Chronic Pain Pharmacology Receptor Pharmacology Consciousness Clinical Trial Cancer Patients Treatment-Resistant Depression Healthcare Workers Safety Adverse Events Clinical Trial

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

The Potential of Psilocybin Administration in Terminal Cancer Patients2019-06-28

Related papers

Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric DisordersPsychiatry and Clinical Psychopharmacology · 2026-03-30 Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15 Psilocybin-induced neurocardiogenic syncope: a case reportPsychopharmacology · 2026-05-28 From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical PracticePharmacology Research & Perspectives · 2026-05-10 A scoping review of mystical-type experiences and mood symptom outcomes in psychedelic therapy clinical trials: comparing life-threatening disease and depressive populationsTherapeutic Advances in Psychopharmacology · 2026-02-28 Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative reviewClinical Neuropsychopharmacology and Addiction · 2025-09-24 Psychedelics produce enduring enhancement of reward responsiveness in male rats.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2026-07-10 Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’Behavioural Pharmacology · 2026-05-06